{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,20]],"date-time":"2026-09-20T18:04:16Z","timestamp":1789927456928,"version":"4.0.1"},"reference-count":62,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2023,5,1]],"date-time":"2023-05-01T00:00:00Z","timestamp":1682899200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2023,5,1]],"date-time":"2023-05-01T00:00:00Z","timestamp":1682899200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2023,5,1]],"date-time":"2023-05-01T00:00:00Z","timestamp":1682899200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2023,5,1]],"date-time":"2023-05-01T00:00:00Z","timestamp":1682899200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2023,5,1]],"date-time":"2023-05-01T00:00:00Z","timestamp":1682899200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2023,5,1]],"date-time":"2023-05-01T00:00:00Z","timestamp":1682899200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2023,5,1]],"date-time":"2023-05-01T00:00:00Z","timestamp":1682899200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Controlled Release"],"published-print":{"date-parts":[[2023,5]]},"DOI":"10.1016\/j.jconrel.2023.04.016","type":"journal-article","created":{"date-parts":[[2023,4,22]],"date-time":"2023-04-22T20:42:37Z","timestamp":1682196157000},"page":"580-590","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":8,"special_numbering":"C","title":["Preclinical validation of a novel therapeutic strategy for choroid plexus carcinoma"],"prefix":"10.1016","volume":"357","author":[{"given":"Brice","family":"Martin","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tyler","family":"Garman","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Madeline","family":"Laramee","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Amy","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiaohu","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Erin","family":"Beck","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kelli","family":"Wilson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Carleen","family":"Klumpp-Thomas","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Crystal","family":"McKnight","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xin","family":"Xu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Natalie","family":"Hagen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"David","family":"Holland","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nadia","family":"Dahmane","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Craig J.","family":"Thomas","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mark","family":"Souweidane","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.jconrel.2023.04.016_bb0005","doi-asserted-by":"crossref","first-page":"470","DOI":"10.1097\/00006123-199803000-00006","article-title":"Choroid plexus carcinomas in childhood: clinical features and prognostic factors","volume":"42","author":"Berger","year":"1998","journal-title":"Neurosurgery"},{"key":"10.1016\/j.jconrel.2023.04.016_bb0010","doi-asserted-by":"crossref","first-page":"580","DOI":"10.1002\/1097-0142(19920115)69:2<580::AID-CNCR2820690250>3.0.CO;2-O","article-title":"Choroid plexus carcinoma of childhood","volume":"69","author":"Packer","year":"1992","journal-title":"Cancer"},{"key":"10.1016\/j.jconrel.2023.04.016_bb0015","doi-asserted-by":"crossref","first-page":"480","DOI":"10.1002\/mpo.2950210705","article-title":"Carcinoma of the choroid plexus: A pediatric experience","volume":"21","author":"Pierga","year":"1993","journal-title":"Med. Pediatr. Oncol."},{"key":"10.1016\/j.jconrel.2023.04.016_bb0020","doi-asserted-by":"crossref","first-page":"745","DOI":"10.1007\/s00701-019-03832-5","article-title":"Management of choroid plexus tumors\u2014an institutional experience","volume":"161","author":"Hosmann","year":"2019","journal-title":"Acta Neurochir."},{"key":"10.1016\/j.jconrel.2023.04.016_bb0025","doi-asserted-by":"crossref","first-page":"179","DOI":"10.1007\/s11060-013-1281-5","article-title":"Gross total resection improves overall survival in children with choroid plexus carcinoma","volume":"116","author":"Sun","year":"2014","journal-title":"J. Neuro-Oncol."},{"key":"10.1016\/j.jconrel.2023.04.016_bb0030","doi-asserted-by":"crossref","first-page":"1086","DOI":"10.1038\/sj.bjc.6600609","article-title":"Choroid plexus tumours","volume":"87","author":"Wolff","year":"2002","journal-title":"Br. J. Cancer"},{"key":"10.1016\/j.jconrel.2023.04.016_bb0035","first-page":"81","article-title":"WHO classification of Tumours of the central nervous system","volume":"6","author":"David","year":"2007","journal-title":"Angew. Chem. Int. Ed."},{"key":"10.1016\/j.jconrel.2023.04.016_bb0040","doi-asserted-by":"crossref","first-page":"353","DOI":"10.1007\/s11060-014-1559-2","article-title":"Effects of adjuvant chemotherapy and radiation on overall survival in children with choroid plexus carcinoma","volume":"120","author":"Sun","year":"2014","journal-title":"J. Neuro-Oncol."},{"key":"10.1016\/j.jconrel.2023.04.016_bb0045","doi-asserted-by":"crossref","first-page":"179","DOI":"10.1007\/s10143-013-0499-1","article-title":"Current management of choroid plexus carcinomas","volume":"37","author":"Sun","year":"2014","journal-title":"Neurosurg. Rev."},{"key":"10.1016\/j.jconrel.2023.04.016_bb0050","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1002\/pbc.27031","article-title":"Pediatric choroid plexus carcinoma: biologically and clinically in need of new perspectives","volume":"65","author":"Zaky","year":"2018","journal-title":"Pediatr. Blood Cancer"},{"key":"10.1016\/j.jconrel.2023.04.016_bb0055","doi-asserted-by":"crossref","first-page":"79","DOI":"10.1016\/j.ijrobp.2009.07.1701","article-title":"The impact of radiotherapy fields in the treatment of patients with choroid plexus carcinoma","volume":"78","author":"Mazloom","year":"2010","journal-title":"Int. J. Radiat. Oncol. Biol. Phys."},{"key":"10.1016\/j.jconrel.2023.04.016_bb0060","doi-asserted-by":"crossref","first-page":"712","DOI":"10.1016\/j.ccell.2015.04.005","article-title":"Cross-species genomics identifies TAF12, NFYC, and RAD54L as choroid plexus carcinoma oncogenes","volume":"27","author":"Tong","year":"2015","journal-title":"Cancer Cell"},{"key":"10.1016\/j.jconrel.2023.04.016_bb0065","doi-asserted-by":"crossref","first-page":"1596","DOI":"10.1038\/s41418-022-00950-z","article-title":"Disruption of GMNC-MCIDAS multiciliogenesis program is critical in choroid plexus carcinoma development","volume":"29","author":"Li","year":"2022","journal-title":"Cell Death Differ."},{"key":"10.1016\/j.jconrel.2023.04.016_bb0070","doi-asserted-by":"crossref","first-page":"2208","DOI":"10.1158\/0008-5472.CAN-18-2565","article-title":"Myc and loss of p53 cooperate to drive formation of choroid plexus carcinoma","volume":"79","author":"Wang","year":"2019","journal-title":"Cancer Res."},{"key":"10.1016\/j.jconrel.2023.04.016_bb0075","doi-asserted-by":"crossref","first-page":"225","DOI":"10.1007\/s11060-015-1965-0","article-title":"Preclinical studies of 5-fluoro-2\u2032-deoxycytidine and tetrahydrouridine in pediatric brain tumors","volume":"126","author":"Morfouace","year":"2016","journal-title":"J. Neuro-Oncol."},{"key":"10.1016\/j.jconrel.2023.04.016_bb0080","article-title":"Textbook of Neuroanesthesia and Neurocritical care","volume":"1","author":"Prabhakar","year":"2019","journal-title":"Anesth. Analg."},{"key":"10.1016\/j.jconrel.2023.04.016_bb0085","doi-asserted-by":"crossref","first-page":"111","DOI":"10.1097\/ANA.0b013e318033da41","article-title":"Intra-arterial drug delivery: a concise review","volume":"19","author":"Joshi","year":"2007","journal-title":"J. Neurosurg. Anesthesiol."},{"key":"10.1016\/j.jconrel.2023.04.016_bb0090","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1007\/BF00172455","article-title":"Osmotic blood-brain barrier disruption and chemotherapy in the treatment of high grade malignant glioma: patient series and literature review","volume":"12","author":"Gumerlock","year":"1992","journal-title":"J. Neuro-Oncol."},{"key":"10.1016\/j.jconrel.2023.04.016_bb0095","doi-asserted-by":"crossref","first-page":"51","DOI":"10.1093\/neurosurgery\/46.1.51","article-title":"Cognitive outcomes and long-term follow-up results after enhanced chemotherapy delivery for primary central nervous system lymphoma","volume":"46","author":"McAllister","year":"2000","journal-title":"Neurosurgery"},{"key":"10.1016\/j.jconrel.2023.04.016_bb0100","doi-asserted-by":"crossref","first-page":"81","DOI":"10.1097\/01376517-199804000-00002","article-title":"Blood-brain barrier disruption for the treatment of malignant brain tumors: The National Program","volume":"30","author":"Doolittle","year":"1998","journal-title":"J. Neurosci. Nurs. J. Am. Assoc. Neurosci. Nurses"},{"key":"10.1016\/j.jconrel.2023.04.016_bb0105","doi-asserted-by":"crossref","first-page":"1086","DOI":"10.1136\/bjophthalmol-2016-309298","article-title":"First-line intra-arterial versus intravenous chemotherapy in unilateral sporadic group D retinoblastoma: evidence of better visual outcomes, ocular survival and shorter time to success with intra-arterial delivery from retrospective review of 20 years of","volume":"101","author":"Munier","year":"2017","journal-title":"Br. J. Ophthalmol."},{"key":"10.1016\/j.jconrel.2023.04.016_bb0110","doi-asserted-by":"crossref","first-page":"1398","DOI":"10.1016\/j.ophtha.2007.12.014","article-title":"A phase I\/II study of direct Intraarterial (ophthalmic artery) chemotherapy with Melphalan for intraocular retinoblastoma. Initial Results","volume":"115","author":"Abramson","year":"2008","journal-title":"Ophthalmology"},{"key":"10.1016\/j.jconrel.2023.04.016_bb0115","first-page":"775","article-title":"Pharmacokinetics of superselective intra-arterial and intravenous [11C]BCNU evaluated by PET","volume":"27","author":"Tyler","year":"1986","journal-title":"J. Nucl. Med."},{"key":"10.1016\/j.jconrel.2023.04.016_bb0120","article-title":"Strategies for improved intra-arterial treatments targeting brain tumors: a systematic review","volume":"10","author":"Huang","year":"2020","journal-title":"Front. Oncol."},{"key":"10.1016\/j.jconrel.2023.04.016_bb0125","first-page":"493","article-title":"Delayed sodium thiosulfate as an otoprotectant against carboplatin-induced hearing loss in patients with malignant brain tumors","volume":"7","author":"Doolittle","year":"2001","journal-title":"Clin. Cancer Res."},{"key":"10.1016\/j.jconrel.2023.04.016_bb0130","doi-asserted-by":"crossref","first-page":"63","DOI":"10.1023\/A:1006457502972","article-title":"Randomized comparison of intra-arterial versus intravenous infusion of ACNU for newly diagnosed patients with glioblastoma","volume":"49","author":"Kochi","year":"2000","journal-title":"J. Neuro-Oncol."},{"key":"10.1016\/j.jconrel.2023.04.016_bb0135","doi-asserted-by":"crossref","first-page":"2350","DOI":"10.1002\/(SICI)1097-0142(20000515)88:10<2350::AID-CNCR20>3.0.CO;2-R","article-title":"Therapy for patients with high grade astrocytoma using intraarterial chemotherapy and radiation therapy","volume":"88","author":"Madajewicz","year":"2000","journal-title":"Cancer"},{"key":"10.1016\/j.jconrel.2023.04.016_bb0140","doi-asserted-by":"crossref","first-page":"67","DOI":"10.1023\/A:1006441104260","article-title":"Intra-arterial cisplatin plus oral etoposide for the treatment of recurrent malignant glioma: A phase II study","volume":"51","author":"Ashby","year":"2001","journal-title":"J. Neuro-Oncol."},{"key":"10.1016\/j.jconrel.2023.04.016_bb0145","doi-asserted-by":"crossref","first-page":"732","DOI":"10.1001\/archophthalmol.2011.5","article-title":"Intra-arterial chemotherapy for the management of retinoblastoma four-year experience","volume":"129","author":"Gobin","year":"2011","journal-title":"Arch. Ophthalmol."},{"key":"10.1016\/j.jconrel.2023.04.016_bb0150","first-page":"48","article-title":"Intra-arterial chemotherapy with osmotic blood-brain barrier disruption for aggressive oligodendroglial tumors: results of a phase i study","volume":"66","author":"Guillaume","year":"2010","journal-title":"Neurosurgery"},{"key":"10.1016\/j.jconrel.2023.04.016_bb0155","doi-asserted-by":"crossref","first-page":"504","DOI":"10.1016\/j.csbj.2015.09.001","article-title":"Searching for drug synergy in complex dose-response landscapes using an interaction potency model","volume":"13","author":"Yadav","year":"2015","journal-title":"Comput. Struct. Biotechnol. J."},{"key":"10.1016\/j.jconrel.2023.04.016_bb0160","first-page":"112","article-title":"Evaluation of drug combination effect using a bliss independence dose-response surface model","volume":"10","author":"Liu","year":"2018","journal-title":"Physiol. Behav."},{"key":"10.1016\/j.jconrel.2023.04.016_bb0165","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1371\/journal.pcbi.1006752","article-title":"Drug combination sensitivity scoring facilitates the discovery of synergistic and efficacious drug combinations in cancer","volume":"15","author":"Malyutina","year":"2019","journal-title":"PLoS Comput. Biol."},{"key":"10.1016\/j.jconrel.2023.04.016_bb0170","doi-asserted-by":"crossref","first-page":"1334","DOI":"10.1016\/j.ajpath.2018.02.009","article-title":"Mice expressing Myc in neural precursors develop choroid plexus and ciliary body tumors","volume":"188","author":"Shannon","year":"2018","journal-title":"Am. J. Pathol."},{"key":"10.1016\/j.jconrel.2023.04.016_bb0175","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1093\/bioinformatics\/bts635","article-title":"STAR: Ultrafast universal RNA-seq aligner","volume":"29","author":"Dobin","year":"2013","journal-title":"Bioinformatics"},{"key":"10.1016\/j.jconrel.2023.04.016_bb0180","doi-asserted-by":"crossref","first-page":"511","DOI":"10.1038\/nbt.1621","article-title":"Transcript assembly and quantification by RNA-Seq reveals unannotated transcripts and isoform switching during cell differentiation","volume":"28","author":"Trapnell","year":"2010","journal-title":"Nat. Biotechnol."},{"key":"10.1016\/j.jconrel.2023.04.016_bb0185","doi-asserted-by":"crossref","first-page":"46","DOI":"10.1038\/nbt.2450","article-title":"Differential analysis of gene regulation at transcript resolution with RNA-seq","volume":"31","author":"Trapnell","year":"2013","journal-title":"Nat. Biotechnol."},{"key":"10.1016\/j.jconrel.2023.04.016_bb0190","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/s13059-014-0550-8","article-title":"Moderated estimation of fold change and dispersion for RNA-seq data with DESeq2","volume":"15","author":"Love","year":"2014","journal-title":"Genome Biol."},{"key":"10.1016\/j.jconrel.2023.04.016_bb0195","doi-asserted-by":"crossref","first-page":"15545","DOI":"10.1073\/pnas.0506580102","article-title":"Gene set enrichment analysis: A knowledge-based approach for interpreting genome-wide expression profiles","volume":"102","author":"Subramanian","year":"2005","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.jconrel.2023.04.016_bb0200","doi-asserted-by":"crossref","first-page":"265","DOI":"10.1038\/modpathol.3800989","article-title":"Platelet-derived growth factor receptor expression and amplification in choroid plexus carcinomas","volume":"21","author":"Nupponen","year":"2008","journal-title":"Mod. Pathol."},{"key":"10.1016\/j.jconrel.2023.04.016_bb0205","doi-asserted-by":"crossref","first-page":"418","DOI":"10.1038\/ncb3327","article-title":"Sonic hedgehog promotes proliferation of notch-dependent monociliated choroid plexus tumour cells","volume":"18","author":"Li","year":"2016","journal-title":"Nat. Cell Biol."},{"key":"10.1016\/j.jconrel.2023.04.016_bb0210","doi-asserted-by":"crossref","DOI":"10.3389\/fphar.2017.00652","article-title":"Molecular guided therapy provides sustained clinical response in refractory choroid plexus carcinoma","volume":"8","author":"Cornelius","year":"2017","journal-title":"Front. Pharmacol."},{"key":"10.1016\/j.jconrel.2023.04.016_bb0215","doi-asserted-by":"crossref","first-page":"767","DOI":"10.1021\/acschemneuro.6b00029","article-title":"Central nervous system multiparameter optimization desirability: application in drug discovery","volume":"7","author":"Wager","year":"2016","journal-title":"ACS Chem. Neurosci."},{"key":"10.1016\/j.jconrel.2023.04.016_bb0220","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1093\/noajnl\/vdaa168","article-title":"Outcome and molecular analysis of young children with choroid plexus carcinoma treated with non-myeloablative therapy: results from the SJYC07 trial","volume":"3","author":"Liu","year":"2021","journal-title":"Neuro-Oncology Adv."},{"key":"10.1016\/j.jconrel.2023.04.016_bb0225","doi-asserted-by":"crossref","first-page":"261","DOI":"10.1007\/s11060-020-03435-6","article-title":"Super selective intra-arterial cerebral infusion of modern chemotherapeutics after blood\u2013brain barrier disruption: where are we now, and where we are going","volume":"147","author":"D\u2019Amico","year":"2020","journal-title":"J. Neuro-Oncol."},{"key":"10.1016\/j.jconrel.2023.04.016_bb0230","doi-asserted-by":"crossref","first-page":"167","DOI":"10.1023\/A:1006229732653","article-title":"Volumetric reduction of a choroid plexus carcinoma using preoperative chemotherapy","volume":"43","author":"Souweidane","year":"1999","journal-title":"J. Neuro-Oncol."},{"key":"10.1016\/j.jconrel.2023.04.016_bb0235","doi-asserted-by":"crossref","first-page":"54","DOI":"10.3171\/2014.12.PEDS14287","article-title":"Purely endoscopic resection of a choroid plexus papilloma of the third ventricle: case report","volume":"16","author":"Santos","year":"2015","journal-title":"J. Neurosurg. Pediatr."},{"key":"10.1016\/j.jconrel.2023.04.016_bb0240","doi-asserted-by":"crossref","first-page":"126","DOI":"10.3171\/2014.12.PEDS14372","article-title":"Neoadjuvant chemotherapy reduces blood loss during the resection of pediatric choroid plexus carcinomas *christian","volume":"16","author":"Schneider","year":"2015","journal-title":"J. Neurosurg. Pediatr. Pediatr."},{"key":"10.1016\/j.jconrel.2023.04.016_bb0245","first-page":"4429","article-title":"Second surgery and the prognosis of choroid plexus carcinoma - results of a meta-analysis of individual cases","volume":"25","author":"Wrede","year":"2005","journal-title":"Anticancer Res."},{"key":"10.1016\/j.jconrel.2023.04.016_bb0250","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1038\/s41467-019-11732-6","article-title":"PPM1D mutations silence NAPRT gene expression and confer NAMPT inhibitor sensitivity in glioma","volume":"10","author":"Fons","year":"2019","journal-title":"Nat. Commun."},{"key":"10.1016\/j.jconrel.2023.04.016_bb0255","first-page":"1","article-title":"Therapeutic strategies for diffuse midline glioma from high- throughput combination drug screening","volume":"11","author":"Lin","year":"2020","journal-title":"Sci. Transl. Med."},{"key":"10.1016\/j.jconrel.2023.04.016_bb0260","doi-asserted-by":"crossref","first-page":"493","DOI":"10.1038\/nm.4296","article-title":"Therapeutic targeting of polycomb and BET bromodomain proteins in diffuse intrinsic pontine gliomas","volume":"23","author":"Piunti","year":"2017","journal-title":"Nat. Med."},{"key":"10.1016\/j.jconrel.2023.04.016_bb0265","doi-asserted-by":"crossref","first-page":"568","DOI":"10.1016\/j.bbrc.2017.11.192","article-title":"A new genetically engineered mouse model of choroid plexus carcinoma","volume":"496","author":"El Nagar","year":"2018","journal-title":"Biochem. Biophys. Res. Commun."},{"key":"10.1016\/j.jconrel.2023.04.016_bb0270","doi-asserted-by":"crossref","first-page":"26","DOI":"10.1158\/1535-7163.MCT-19-0019","article-title":"The novel ATR inhibitor BAY 1895344 is efficacious as monotherapy and combined with DNA damage\u2013inducing or repair\u2013compromising therapies in preclinical cancer models","volume":"19","author":"Wengner","year":"2020","journal-title":"Mol. Cancer Ther."},{"key":"10.1016\/j.jconrel.2023.04.016_bb0275","doi-asserted-by":"crossref","first-page":"80","DOI":"10.1158\/2159-8290.CD-20-0868","article-title":"First-in-human trial of the oral ataxia telangiectasia and rad3-related (Atr) inhibitor bay 1895344 in patients with advanced solid tumors","volume":"11","author":"Yap","year":"2021","journal-title":"Cancer Discov."},{"key":"10.1016\/j.jconrel.2023.04.016_bb0280","doi-asserted-by":"crossref","first-page":"7293","DOI":"10.1021\/acs.jmedchem.0c00369","article-title":"Damage incorporated: discovery of the potent, highly selective, orally available ATR inhibitor BAY 1895344 with favorable pharmacokinetic properties and promising efficacy in monotherapy and in combination treatments in preclinical tumor models","volume":"63","author":"L\u00fccking","year":"2020","journal-title":"J. Med. Chem."},{"key":"10.1016\/j.jconrel.2023.04.016_bb0285","doi-asserted-by":"crossref","first-page":"784","DOI":"10.1002\/pbc.25436","article-title":"Choroid plexus carcinoma in children: the head start experience","volume":"62","author":"Zaky","year":"2015","journal-title":"Pediatr. Blood Cancer"},{"key":"10.1016\/j.jconrel.2023.04.016_bb0290","doi-asserted-by":"crossref","first-page":"1515","DOI":"10.1007\/s10147-019-01517-8","article-title":"Tandem high-dose chemotherapy with topotecan\u2013thiotepa\u2013carboplatin and melphalan\u2013etoposide\u2013carboplatin regimens for pediatric high-risk brain tumors","volume":"24","author":"Choi","year":"2019","journal-title":"Int. J. Clin. Oncol."},{"key":"10.1016\/j.jconrel.2023.04.016_bb0295","doi-asserted-by":"crossref","first-page":"2316","DOI":"10.1002\/pbc.25174","article-title":"Proposed strategy for the use of high-dose chemotherapy with stem cell rescue and intrathecal Topotecan without whole-brain irradiation for infantile classic","volume":"61","author":"Yamada","year":"2014","journal-title":"Pediatr. Blood Cancer"},{"key":"10.1016\/j.jconrel.2023.04.016_bb0300","first-page":"673","article-title":"Moderate-to-strong expression of FGFR3 and TP53 alterations in a subpopulation of choroid plexus tumors","volume":"35","author":"Granberg","year":"2020","journal-title":"Histol. Histopathol."},{"key":"10.1016\/j.jconrel.2023.04.016_bb0305","first-page":"726","article-title":"Use of intra-arterial chemotherapy for retinoblastoma: results of a survey","volume":"7","author":"Grigorovski","year":"2014","journal-title":"Int. J. Ophthalmol."},{"key":"10.1016\/j.jconrel.2023.04.016_bb0310","first-page":"1","article-title":"Symposium recent advances and challenges in the management of retinoblastoma globe - saving treatments","volume":"17","author":"Balasopoulou","year":"2017","journal-title":"BMC Ophthalmol."}],"container-title":["Journal of Controlled Release"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0168365923002663?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0168365923002663?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,29]],"date-time":"2025-09-29T16:44:41Z","timestamp":1759164281000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0168365923002663"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,5]]},"references-count":62,"alternative-id":["S0168365923002663"],"URL":"https:\/\/doi.org\/10.1016\/j.jconrel.2023.04.016","relation":{},"ISSN":["0168-3659"],"issn-type":[{"value":"0168-3659","type":"print"}],"subject":[],"published":{"date-parts":[[2023,5]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Preclinical validation of a novel therapeutic strategy for choroid plexus carcinoma","name":"articletitle","label":"Article Title"},{"value":"Journal of Controlled Release","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jconrel.2023.04.016","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2023 Elsevier B.V. All rights reserved.","name":"copyright","label":"Copyright"}]}}